Zum Inhalt
Zur Navigation
Zur Suche

Header Image

Navigation

Subnavigation

AbD Customer Updates

AbD customer updates cover science-based topics and collaborations arising from the research antibody segment of MorphoSys’s AbD Serotec.

09/23/2008	e2v to Establish Next Generation Biosensor System Using AbD Serotec-generated HuCAL Antibodies
09/10/2008	AbD Serotec to Present Next Generation Calibrators and Controls at 6th International Congress on Autoimmunity
07/15/2008	MorphoSys and Integrated BioTherapeutics Provide Update Regarding USAMRIID Biodefense Project
01/09/2008	NIDDK Scientists Detect New Epitope on HIV-1 Protein gp41 Using AbD Serotec-generated Recombinant Mini-antibody
02/12/2007	AbD Serotec and Thermo Fisher Scientific Sign Technology Agreement
12/04/2006	Scientists at Hokkaido University to Analyze Parkinson’s and Alzheimer’s Disease Pathways using HuCAL-based Antibodies
08/04/2006	AbD Serotec Opens New U.S. Office in Research Triangle Region
05/15/2006	MorphoSys’ Antibodies by Design Establishes Antibody Series in Partnership with Japanese Kazusa DNA Research Institute
02/20/2006	MorphoSys’ Antibodies by Design and Chimera Biotec Announce Cooperation and Co-Marketing Agreement
11/24/2005	NIDDK Scientists Analyze HuCAL-based Mini-antibodies as a Potential Basis for Future HIV-1 Therapeutics
09/05/2005	MorphoSys’s Antibodies by Design Introduces Series of HuCAL GOLD Recombinant Antibodies at Biogenesis
06/17/2005	MorphoSys Antibodies by Design, ProQinase and Natural and Medical Sciences Institute receive BMBF-promotion for Kinome-project
06/06/2005	MorphoSys’ Antibodies by Design Increases Throughput in Generating Antibodies Using Automation Software
04/18/2005	MorphoSys’ Antibodies by Design and JPT Peptide Technologies Announce Cooperation Agreement
03/21/2005	MorphoSys’ Antibodies by Design and Armbruster Biotechnology obtain BMBF Grant for Bone Cancer Project
11/23/2004	EMD Biosciences, Inc. and MorphoSys’ Antibodies by Design offer first recombinant antibody